BUENA, N.J., Jan. 8, 2015 /PRNewswire/ -- IGI Laboratories, Inc. (NYSE Amex: IG), a New Jersey based specialty generic pharmaceutical company, will be presenting at the 33RD Annual J.P. Morgan Healthcare Conference. The Conference will take place on January 12-15, 2015 at the Westin St. Francis Hotel in San Francisco, California.
Jason Grenfell-Gardner, CEO and President and Jenniffer Collins, Chief Financial Officer of IGI Laboratories, Inc. will present on Thursday January 15, 2015 at 10:30 a.m. PT.
The presentation will be webcast and will be accessible online on the investors section of the Company's website at http://www.igilabs.com. A replay will be available for 90 days.
About IGI Laboratories, Inc.
IGI Laboratories is a specialty generic drug development and manufacturing company. Our mission is to be a leading player in the specialty generic prescription drug market.
SOURCE IGI Laboratories, Inc.